share_log

iBio Inc | 3: Initial statement of beneficial ownership of securities-Director Arkowitz David

iBio Inc | 3: Initial statement of beneficial ownership of securities-Director Arkowitz David

iBio Inc | 3:首次持股聲明-董事 Arkowitz David
美股SEC公告 ·  11/26 05:32

Moomoo AI 已提取核心訊息

On 11/21/2024, David Arkowitz filed an initial statement of beneficial ownership with the SEC for iBio Inc. This filing, known as Form 3, indicates Arkowitz's position as a director and 10% owner of the company. Despite the filing, it is noted that no securities are beneficially owned by Arkowitz at this time.The document was submitted in compliance with Section 16(a) of the Securities Exchange Act of 1934. The filing was completed by Arkowitz individually, as indicated by the signature dated 11/25/2024. This form is a standard requirement for individuals who hold significant positions or ownership in a company, ensuring transparency in securities ownership.
On 11/21/2024, David Arkowitz filed an initial statement of beneficial ownership with the SEC for iBio Inc. This filing, known as Form 3, indicates Arkowitz's position as a director and 10% owner of the company. Despite the filing, it is noted that no securities are beneficially owned by Arkowitz at this time.The document was submitted in compliance with Section 16(a) of the Securities Exchange Act of 1934. The filing was completed by Arkowitz individually, as indicated by the signature dated 11/25/2024. This form is a standard requirement for individuals who hold significant positions or ownership in a company, ensuring transparency in securities ownership.
在2024年11月21日,大衛·阿科維茨向SEC提交了iBio公司的有益所有權初始聲明。 這份被稱爲3號表格的申報顯示阿科維茨擔任董事兼公司10%的持有人。 儘管進行了這一申報,但指出目前阿科維茨並未持有任何證券。\n該文件是根據1934年證券交易法案第16(a)條的規定提交的。 申報是由阿科維茨個人完成的,如簽名日期11月25日所示。 這個表格是公司中擔任重要職務或擁有權益的個人的標準要求,確保證券所有權的透明度。
在2024年11月21日,大衛·阿科維茨向SEC提交了iBio公司的有益所有權初始聲明。 這份被稱爲3號表格的申報顯示阿科維茨擔任董事兼公司10%的持有人。 儘管進行了這一申報,但指出目前阿科維茨並未持有任何證券。\n該文件是根據1934年證券交易法案第16(a)條的規定提交的。 申報是由阿科維茨個人完成的,如簽名日期11月25日所示。 這個表格是公司中擔任重要職務或擁有權益的個人的標準要求,確保證券所有權的透明度。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息